헬스케어 수탁제조 시장 시장 규모, 점유율, 동향 분석 보고서 : 유형별(의료기기, 의약품), 최종 용도별(의료기기 기업), 지역별, 부문별 예측(2023-2030년)

Healthcare Contract Manufacturing Market Growth & Trends

The global healthcare contract manufacturing market size is expected to reach USD 347.5 billion by 2030, expanding at a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. The changing regulatory landscape coupled with rising offshoring to emerging countries is anticipated to propel the healthcare contract manufacturing market growth over the forecast period. For instance, in June 2023, FUJIFILM Diosynth Biotechnologies announced to have a commercial office in Tokyo, offering contract development and manufacturing services for advanced therapies and biologics to Asian pharmaceutical and biotechnology companies.

Due to the emergence of infections, such as COVD-19 many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes, as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on large scale. Hence, the pandemic had a positive impact on this industry.

Increasing demand for advanced products is another factor driving the industry scale. Original Equipment Manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly in developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Healthcare Contract Manufacturing Market Report Highlights

• The pharmaceutical segment dominated the market with a share of 65.1% in 2022 owing to a low manufacturing budget and highly sophisticated contract manufacturing service offerings
• The medical devices segment is expected to be the fastest-growing segment with a CAGR of 9.7% owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
• Cardiology is the dominant category in the medical device contract manufacturing segment, with a revenue share of 20.6% in 2022, owing to the rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions
• Asia Pacific is expected to witness lucrative growth of 10.6% from 2023 to 2030, owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region
• Based on end use segment, the pharmaceutical and biopharmaceutical companies category held the highest revenue share of 55.6% in 2022. High segment shares are mainly due to the increasing rate of biologics approval across the globe, thereby boosting demand for its bulk production contract manufacturing services

Table of Content

Chapter 1. Research Methodology And Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment Definitions
  • 1.1.2. Type
  • 1.1.3. End Use
• 1.2. Regional Scope
• 1.3. Estimates And Forecast Timeline
• 1.4. Objectives
  • 1.4.1. Objective-1
  • 1.4.2. Objective-2
  • 1.4.3. Objective-3
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information Or Data Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
  • 1.9.2. Parent Market Analysis
• 1.10. List Of Secondary Sources
• 1.11. List Of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Healthcare Contract Manufacturing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Implementation of international standards by contract manufacturers
    • 3.2.1.2. Drug shortage driving the demand for pharmaceutical development
    • 3.2.1.3. Commercial success of biologics for clinical use
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Regulatory and legal compliance
    • 3.2.2.2. Threat of information loss
  • 3.2.3. Industry Challenges
    • 3.2.3.1. Managing relationships
• 3.3. Healthcare Contract Manufacturing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat Of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Healthcare Contract Manufacturing Market: Type Segment Analysis

• 4.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
• 4.2 Medical Device
  • 4.2.1 Medical device market, 2018 - 2030 (USD Million)
  • 4.2.2 Service
    • 4.2.2.1 Accessories manufacturing
    • 4.2.2.1.1 Accessories manufacturing market, 2018 - 2030 (USD Million)
    • 4.2.2.2 Assembly manufacturing
    • 4.2.2.2.1 Assembly manufacturing market, 2018 - 2030 (USD Million)
    • 4.2.2.3 Component manufacturing
    • 4.2.2.3.1 Component manufacturing market, 2018 - 2030 (USD Million)
    • 4.2.2.4 Device manufacturing
    • 4.2.2.4.1 Device manufacturing market, 2018 - 2030 (USD Million)
  • 4.2.3 Therapeutic area
    • 4.2.3.1 Cardiology
    • 4.2.3.1.1 Cardiology market, 2018 - 2030 (USD Million)
    • 4.2.3.2 Diagnostic imaging
    • 4.2.3.2.1 Diagnostic imaging market, 2018 - 2030 (USD Million)
    • 4.2.3.3 Orthopedic
    • 4.2.3.3.1 Orthopedic market, 2018 - 2030 (USD Million)
    • 4.2.3.4 IVD
    • 4.2.3.4.1 IVD market, 2018 - 2030 (USD Million)
    • 4.2.3.5 Ophthalmic
    • 4.2.3.5.1 Ophthalmic market, 2018 - 2030 (USD Million)
    • 4.2.3.6 General & plastic surgery
    • 4.2.3.6.1 General & plastic surgery market, 2018 - 2030 (USD Million)
    • 4.2.3.7 Drug delivery
    • 4.2.3.7.1 Drug delivery market, 2018 - 2030 (USD Million)
    • 4.2.3.8 Dental
    • 4.2.3.8.1 Dental market, 2018 - 2030 (USD Million)
    • 4.2.3.9 Endoscopy
    • 4.2.3.9.1 Endoscopy market, 2018 - 2030 (USD Million)
    • 4.2.3.10 Diabetes care
    • 4.2.3.10.1 Diabetes care market, 2018 - 2030 (USD Million)
    • 4.2.3.11 Others
    • 4.2.3.11.1 Others market, 2018 - 2030 (USD Million)
• 4.3 Pharmaceutical
  • 4.3.1 Pharmaceutical market, 2018 - 2030 (USD Million)
  • 4.3.2 Service
    • 4.3.2.1 API/bulk drugs
    • 4.3.2.1.1 API/bulk drugs market, 2018 - 2030 (USD Million)
    • 4.3.2.2 Advanced drug delivery formulations
    • 4.3.2.2.1 Advanced drug delivery formulations market, 2018 - 2030 (USD Million)
    • 4.3.2.3 Packaging
    • 4.3.2.3.1 Packaging market, 2018 - 2030 (USD Million)
    • 4.3.2.4 Finished dose formulations
    • 4.3.2.4.1 Finished dose formulations market, 2018 - 2030 (USD Million)
    • 4.3.2.4.2 Solid
    • 4.3.2.4.2.1 Solid market, 2018 - 2030 (USD Million)
    • 4.3.2.4.3 Liquid
    • 4.3.2.4.3.1 Liquid market, 2018 - 2030 (USD Million)
    • 4.3.2.4.4 Semisolid formulations
    • 4.3.2.4.4.1 Semisolid formulations market, 2018 - 2030 (USD Million)

Chapter 5. Healthcare Contract Manufacturing Market: End Use Segment Analysis

• 5.1 Healthcare Contract Manufacturing: Market Share Analysis, 2022 & 2030
• 5.2 Medical Device Companies
  • 5.2.1 Medical device companies market, 2018 - 2030 (USD Million)
• 5.3 Pharmaceutical & Biopharmaceutical Companies
  • 5.3.1 Pharmaceutical & Biopharmaceutical Companies market, 2018 - 2030 (USD Million)
• 5.4 Others
  • 5.4.1 Others market, 2018 - 2030 (USD Million)

Chapter 6. Healthcare Contract Manufacturing Market: Regional Analysis

• 6.1. Regional Market Share Analysis, 2022 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. North America
  • 6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
• 6.5. Europe
  • 6.5.1. UK
    • 6.5.1.1. Key Country Dynamics
    • 6.5.1.2. Competitive Scenario
    • 6.5.1.3. Regulatory Framework
    • 6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
  • 6.5.2. Germany
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
  • 6.5.3. France
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
  • 6.5.4. Italy
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
  • 6.5.5. Spain
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
  • 6.5.6. Denmark
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Denmark Market Estimates and Forecasts, 2018 - 2030
  • 6.5.7. Sweden
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030
  • 6.5.8. Norway
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Norway Market Estimates and Forecasts, 2018 - 2030
  • 6.5.9. Belgium
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Belgium Market Estimates and Forecasts, 2018 - 2030
  • 6.5.10. Netherlands
    • 6.5.10.1. Key Country Dynamics
    • 6.5.10.2. Competitive Scenario
    • 6.5.10.3. Regulatory Framework
    • 6.5.10.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
• 6.6. Asia Pacific
  • 6.6.1. Japan
    • 6.6.1.1. Key Country Dynamics
    • 6.6.1.2. Competitive Scenario
    • 6.6.1.3. Regulatory Framework
    • 6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
  • 6.6.2. India
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
  • 6.6.4. South Korea
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
  • 6.6.5. Australia
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
  • 6.6.6. Thailand
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
  • 6.6.7. Philippines
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Philippines Market Estimates and Forecasts, 2018 - 2030
  • 6.6.8. Malaysia
    • 6.6.8.1. Key Country Dynamics
    • 6.6.8.2. Competitive Scenario
    • 6.6.8.3. Regulatory Framework
    • 6.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
  • 6.6.9. New Zealand
    • 6.6.9.1. Key Country Dynamics
    • 6.6.9.2. Competitive Scenario
    • 6.6.9.3. Regulatory Framework
    • 6.6.9.4. New Zealand Market Estimates and Forecasts, 2018 - 2030
  • 6.6.10. Singapore
    • 6.6.10.1. Key Country Dynamics
    • 6.6.10.2. Competitive Scenario
    • 6.6.10.3. Regulatory Framework
    • 6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
• 6.7. Latin America
  • 6.7.1. Brazil
    • 6.7.1.1. Key Country Dynamics
    • 6.7.1.2. Competitive Scenario
    • 6.7.1.3. Regulatory Framework
    • 6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
  • 6.7.2. Mexico
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
  • 6.7.4. Colombia
    • 6.7.4.1. Key Country Dynamics
    • 6.7.4.2. Competitive Scenario
    • 6.7.4.3. Regulatory Framework
    • 6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
  • 6.7.5. Chile
    • 6.7.5.1. Key Country Dynamics
    • 6.7.5.2. Competitive Scenario
    • 6.7.5.3. Regulatory Framework
    • 6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
• 6.8. MEA
  • 6.8.1. South Africa
    • 6.8.1.1. Key Country Dynamics
    • 6.8.1.2. Competitive Scenario
    • 6.8.1.3. Regulatory Framework
    • 6.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
  • 6.8.2. Saudi Arabia
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • 6.8.3. UAE
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
  • 6.8.4. Kuwait
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. Kuwait Market Estimates and Forecasts, 2018 - 2030
  • 6.8.5. Israel
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
  • 7.1.1. Innovators
  • 7.1.2. Market Leaders
  • 7.1.3. Emerging Players
  • 7.1.4. Company Market Share Analysis, 2022
• 7.2. Company Profiles
  • 7.2.1 Nordson Corporation.
    • 7.2.1.1 Company overview
    • 7.2.1.2 Financial performance
    • 7.2.1.3 Service benchmarking
    • 7.2.1.4 Strategic initiatives
  • 7.2.2 Integer Holdings Corporation
    • 7.2.2.1 Company overview
    • 7.2.2.2 Financial performance
    • 7.2.2.3 Service benchmarking
    • 7.2.2.4 Strategic initiatives
  • 7.2.3 Jabil Inc.
    • 7.2.3.1 Company overview
    • 7.2.3.2 Financial performance
    • 7.2.3.3 Service benchmarking
    • 7.2.3.4 Strategic initiatives
  • 7.2.4 Viant Technology LLC
    • 7.2.4.1 Company overview
    • 7.2.4.2 Service benchmarking
    • 7.2.4.3 Strategic initiatives
  • 7.2.5 FLEX LTD.
    • 7.2.5.1 Company overview
    • 7.2.5.2 Financial performance
    • 7.2.5.3 Service benchmarking
    • 7.2.5.4 Strategic initiatives
  • 7.2.6 Celestica Inc.
    • 7.2.6.1 Company overview
    • 7.2.6.2 Financial performance
    • 7.2.6.3 Service benchmarking
    • 7.2.6.4 Strategic initiatives
  • 7.2.7 Sanmina Corporation
    • 7.2.7.1 Company overview
    • 7.2.7.2 Financial performance
    • 7.2.7.3 Service benchmarking
    • 7.2.7.4 Strategic initiatives
  • 7.2.8 Plexus Corp.
    • 7.2.8.1 Company overview
    • 7.2.8.2 Financial performance
    • 7.2.8.3 Service benchmarking
    • 7.2.8.4 Strategic initiatives
  • 7.2.9 Phillips-Medisize
    • 7.2.9.1 Company overview
    • 7.2.9.2 Service benchmarking
    • 7.2.9.3 Strategic initiatives
  • 7.2.10 West Pharmaceutical Services, Inc.
    • 7.2.10.1 Company overview
    • 7.2.10.2 Financial performance
    • 7.2.10.3 Service benchmarking
    • 7.2.10.4 Strategic initiatives
  • 7.2.11 Synecco Ltd.
    • 7.2.11.1 Company overview
    • 7.2.11.2 Service benchmarking
  • 7.2.12 Catalent, Inc.
    • 7.2.12.1 Company overview
    • 7.2.12.2 Financial performance
    • 7.2.12.3 Service benchmarking
    • 7.2.12.4 Strategic initiatives
  • 7.2.13 Thermo Fisher Scientific Inc.
    • 7.2.13.1 Company overview
    • 7.2.13.2 Financial performance
    • 7.2.13.3 Service benchmarking
    • 7.2.13.4 Strategic initiatives
  • 7.2.14 Recipharm AB.
    • 7.2.14.1 Company overview
    • 7.2.14.2 Financial performance
    • 7.2.14.3 Service benchmarking
    • 7.2.14.4 Strategic initiatives
  • 7.2.15 Boehringer Ingelheim International GmbH
    • 7.2.15.1 Company overview
    • 7.2.15.2 Financial performance
    • 7.2.15.3 Service benchmarking
    • 7.2.15.4 Strategic initiatives
  • 7.2.16 Lonza
    • 7.2.16.1 Company overview
    • 7.2.16.2 Financial performance
    • 7.2.16.3 Service benchmarking
    • 7.2.16.4 Strategic initiatives
  • 7.2.17 Samsung Biologics
    • 7.2.17.1 Company overview
    • 7.2.17.2 Financial performance
    • 7.2.17.3 Service benchmarking
    • 7.2.17.4 Strategic initiatives
  • 7.2.18 WuXi AppTec
    • 7.2.18.1 Company overview
    • 7.2.18.2 Financial performance
    • 7.2.18.3 Service benchmarking
    • 7.2.18.4 Strategic initiatives
  • 7.2.19 FUJIFILM Diosynth Biotechnologies
    • 7.2.19.1 Company overview
    • 7.2.19.2 Financial performance
    • 7.2.19.3 Service benchmarking
    • 7.2.19.4 Strategic initiatives
  • 7.2.20 Cambrex Corporation
    • 7.2.20.1 Company overview
    • 7.2.20.2 Financial performance
    • 7.2.20.3 Service benchmarking
    • 7.2.20.4 Strategic initiatives

Chapter 8. KoL Commentary/Recommendations